Japanese researchers discover a way to perform two different chemical reactions in one vessel, potentially cutting costs and waste in pharmaceutical synthesis.

Developing high-performance pharmaceuticals and materials often means running multiple chemical reactions in carefully controlled steps, with each requiring its own reagents, catalysts and conditions. The process is energy-intensive, costly and produces significant waste.

Now, a research team from Chiba University, Japan, has unveiled a method that could dramatically simplify this process – performing two completely different reactions sequentially in a single container, using just one inexpensive cerium-based catalyst.

The approach, dubbed “redox-adaptive auto-tandem catalysis”, exploits cerium’s unique ability to switch between two oxidation states. In one state it drives a ring-forming reaction; in the other, it catalyses oxidation. As the reactions proceed, cerium flips between states, effectively acting as a chemical “chameleon” that adapts to the needs of each step.

A happy accident

The discovery grew out of a chance laboratory mishap. When a cerium reaction flask was accidentally left exposed to air, researchers noticed an unexpected product forming. That serendipitous observation led Associate Professor Shinji Harada and colleagues Tetsuhiro Nemoto and Nanami Tsuji to investigate further.

“We realised cerium could autonomously change roles, catalysing very different reactions one after the other,” said Harada. “This opens the door to simpler, cleaner, and more efficient synthetic chemistry.”

Why it matters for pharma

The team successfully used the method to create α-hydroxylated cyclopentenones, compounds valuable in pharmaceutical synthesis, achieving high yields under mild conditions without hazardous reagents or specialist equipment.

For the pharmaceutical industry, this could offer a greener, lower-cost pathway to producing complex molecules. By reducing the number of steps, energy requirements and waste, the approach aligns with the sector’s growing emphasis on sustainable manufacturing and faster, more efficient drug development.

Looking ahead

The Chiba University team plans to expand the technique to a broader range of reactions relevant to both pharmaceuticals and functional materials. If successful, the method could accelerate R&D pipelines while contributing to more environmentally responsible production.

Their findings were published in ACS Catalysis on August 3, 2025.